ROGEL CANCER CENTER

ANN ARBOR, MI - A $7.6-million gift to the University of Michigan’s Rogel Cancer Center will further research into lung cancer treatments. The specific cancer is known as ALK-positive, or non-small cell lung cancer, which affects about 100,000 people globally. “We are very impressed with the talented, multidisciplinary team that the Rogel Cancer Center has brought together to take on this problem,” Tam said in a statement. ALK-positive lung cancer has a high risk of spreading to other parts of the body. Merajver is the lead investigator for the ALK-positive lung cancer initiative, and will implement expertise from the fields of thoracic oncology and surgery, genetics, molecular pharmacology, cell biology, pathology and more.

U-M Regent Ron Weiser has committed $30 million to establish new prostate cancer center on university's medical campus.

The National Cancer Institute has awarded researchers at the University of Michigan with a $13 million grant to study how exposure to environmental contaminants can impact individuals’ risk of developing cancer.

A new study from the University of Michigan’s Rogel Cancer Center finds that Metro Detroit’s Middle Eastern and North African communities face fear, discrimination and other significant barriers that impact their health.

ANN ARBOR As overwhelmed healthcare systems across the country continue to grapple with COVID-19, thousands of cancer patients have had surgeries and other treatments postponed during the health crisis. Drawing on large, national cancer data sets, the OncCOVID app helps assess what risks a patient faces from receiving immediate treatment versus delayed treatment based on their individual characteristics. The app also takes into consideration the impact of COVID-19 on that individuals local community. But each time a cancer patient goes to the hospital to receive care, theyre also putting themselves at higher risk of contracting COVID-19. A series of factors may contribute to the decision by a care provider to recommend delaying or proceeding with cancer treatment, including their capacity to treat local cancer patients safely during the pandemic.